RHOJ and neoplasm: Kim et al. used a mouse model to show that blocking RhoJ inhibits tumor angiogenesis by activating the RhoA-ROCK signaling pathway in tumor endothelial cells and destroying the pre-formed tumor blood vessels, ultimately leading to the failure of the tumor vascular system 19.